Emily Afshari

Emily Afshari has experience in various roles within the pharmaceutical industry. Emily started their career as a Clinical Research Associate at Brigham and Women's Hospital in 2009. Emily then became a Clinical Research Coordinator before transitioning to the role of In-House Clinical Research Associate at Cubist Pharmaceuticals in 2012. Emily also served as a Clinical Documentation Specialist at Cubist Pharmaceuticals. In 2015, they worked as a Sr. Clinical Research Associate and Inspection Readiness Lead at Synta Pharmaceuticals. Emily later became a Clinical Project Manager at Cerulean Pharma, Inc. and then at Entasis Therapeutics. In 2019, they joined Spero Therapeutics as an Associate Director of Clinical Operations before being promoted to Director of Clinical Operations. Emily currently holds the position of Director of Alliance Management at Spero Therapeutics.

Emily Afshari has a Bachelor of Science (BS) degree in Brain and Cognitive Science from the University of Rochester. Additionally, they hold a Master of Business Administration (M.B.A.) degree from the Babson F.W. Olin Graduate School of Business.